Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|December 5, 1998
Phase II study of adozelesin in untreated metastatic breast cancerM Cristofanilli, W J Bryan, L L Miller, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
U.S. prevalence of endocrine therapy-naïve locally advanced or metastatic breast cancerA P Nunes, C Liang, W J Gradishar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancerW J Gradishar, S B Wedam, M Jahanzeb, et al.
Cancer|December 18, 2001
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)W J Gradishar, P Stephenson, D J Glover, et al.
Breast Cancer Research and Treatment|July 5, 2017
A pilot study of cabergoline for the treatment of metastatic breast cancerRicardo Costa, C A Santa-Maria, D M Scholtens, et al.
Cancer Treatment Reviews|March 11, 2017
Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasisR Costa, N Gill, A W Rademaker, et al.
Breast (Edinburgh, Scotland)|June 16, 2017
Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclibR Costa, R B Costa, Sarah M Talamantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectivesR Costa, B A Carneiro, D A Wainwright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trialK L Tedesco, A D Thor, D H Johnson, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancerM S Tallman, A W Rademaker, L Jahnke, et al.
Pageof 5